Chr. Hansen achieved strong results in 2017/18, and growth is set to continue in 2018/19. Based on good progress in strategic focus areas, the company raises ambitions to 9 to 11 % organic growth next year.

CEO Mauricio Graber says: “2017/18 was another good year for Chr. Hansen, and we finished strongly in Q4 driven by Food Cultures & Enzymes and Health & Nutrition. We achieved all the overall financial targets that we set at the beginning of the year, in spite of currency headwinds impacting both revenues and earnings, with organic growth reaching 9 %, EBIT margin before special items increasing to 29.2 %, and free cash flow before special items and acquisitions increasing by 4 % to EUR 196 m. For the full year, Food Cultures & Enzymes delivered strong growth organic of 12 %, performing well above the long-term ambition of growing 7 to 8 % per year, while Health & Nutrition and Natural Colours delivered moderate growth and grew by 8 % and 5 %, respectively.”